Assistant Professor, Medicine, Perelman School of Medicine
Hematology
Dr. Elizabeth O. Hexner, MD
|
|
Give Review
Doctor Elizabeth O. Hexner, MD practices Hematology. She graduated from Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care She has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Elizabeth O. Hexner is a published doctor and has 46 publications published. The lastest was: 'Infusion of CD3/CD28 co-stimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.' Dr. Elizabeth O. Hexner is registered with Medicare and accepts Medicare payments.
Publications
- The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.
- Infusion of CD3/CD28 co-stimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance enGraftment.
- Phase I dose escalation study of lestaurtinib in patients with myelofibrosis.
- AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid Cells through interactions with poly(A)-binding protein.
- Three-year efficacy, oVerall survival, and safety of ruxolitinib therapy in patients with myelofibrosis from the COMFORT-I study.
- A Common, Under-recognized Cause of Elevated Serum Erythropoietin.
- Acute cholecystitis is a common complication following allogeneic SCT and is associated with use of total parenteral nutrition.
- Phase III clinical trial steroids/mycophenolate mofetil vs steroids/placebo as therapy for Acute graft-versus-host disease: BMT CTN 0802.
- Early donor chimerism levels predict relapse and survival after allogeneic stem-Cell transplantation with reduced intensity conditioning.
- Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice.
- Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia Vera or essential thrombocythaemia with JAK2-V617F mutation.
- Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?
- Receipt of maintenance therapy is most predictive of survival in older Acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.
- A Pilot Study of Prophylactic Ex Vivo Co-Stimulated Donor Leukocyte Infusions After Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation.
- The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
- Intrinsic resistance to JAK2 inhibition in myelofibrosis.
- miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic Cell growth and differentiation.
- Maintenance of hematopoietic stem Cells through regulation of Wnt and mTOR pathways.
- Blockade of lymphocyte chemotaxis in visceral Graft-versus-host disease.
- Myelofibrosis 2012: it's complicated.
- AUF-1 and YB-1 are critical determinants of ?-globin mRNA expression in erythroid Cells.
- AML1 is overexpressed in patients with Myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2.
- A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory Acute myelogenous leukemia.
- Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem Cell transplantation.
- Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid Cells from patients with myeloproliferative d...
- Umbilical cord blood xenoGrafts in immunodeficient mice reveal that T cells enhance hematopoietic enGraftment beyond overcoming immune barriers by stimulating stem cel...
- JAK2 V617F: implications for Thrombosis in myeloproliferative diseases.
- CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from Acute to chronic graft-versus-host disease.
- Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem Cells.
- Primary myelofibrosis (PMF), post Polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Co...
- The role of T cells in hematopoietic stem cell enGraftment.
- RNA interference for treating haematological Malignancies.
- Host-reactive CD8+ memory stem cells in Graft-versus-host disease.
- Alloreactive memory T cells are responsible for the persistence of Graft-versus-host disease.
- Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating Acute graft-versus-host disease but retain graft-versus-leukemia activity.
- Thiamine-responsive megaloblastic Anemia: identification of novel compound heterozygotes and mutation update.
- Trisomy 8 in an allogeneic stem Cell transplant recipient representative of a donor-derived constitutional abnormality.
- The Cell cycle regulator CDC25A is a target for JAK2V617F oncogene.
- Fluorescent in situ hybridization of a skin biopsy: An adjunctive tool to support a diagnosis of Graft-versus-host disease.
- Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating Graft-versus-host disease.
- Targeted signal transduction therapies in Myeloid malignancies.
- Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory Acute GVHD.
- Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating Graft-versus-host dis...
- A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
Schools
Columbia University College of Physicians And Surgeons
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
New York Presbyterian Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1366486250 | |
| NPPES Provider LastName | HEXNER | |
| NPPES Provider FirstName | ELIZABETH | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 200.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366486250 |
| Last Name Of The Provider | HEXNER |
| First Name Of The Provider | ELIZABETH |
| View All |
Similar Doctors
|
|
Dr. Carlyn R. Tan, MD |
|
|
Dr. Elena Shagisultanova, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Olszanski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hayley M. Knollman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mary Ellen Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajan Singla, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sheikh A. Ali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Barry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gamil S. Hanna, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael Bromberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arnon I. Dreyfuss, MD |
|
|
Dr. Jongming Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee P. Schacter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph J. Vadakara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Massimo Cristofanilli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunita D. Nasta, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Bernard Deitch, MD
This Doctor is OpenDoctor Recommended.
|